Craig-Hallum analyst Alex Fuhrman initiated coverage of LifeVantage (LFVN) with a Buy rating and $35 price target
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LFVN:
- LifeVantage announces results of third-party cell study of health weight stack
- LifeVantage launches 2025 vision with ‘Drive ERA’
- LifeVantage price target raised to $30 from $26 at Lake Street
- Exxon and Shell cautious on Q4, Flutter cuts guidance: Morning Buzz
- Morning Movers: AngioDynamics jumps following results and guidance raise